Digital Technology for Sleep and Homelessness
Diagnosis and Treatment of Sleep Apnea in Shelter Residents
University Health Network, Toronto
100 participants
Oct 20, 2021
INTERVENTIONAL
Conditions
Summary
In Canada, 35,000 people are experiencing homelessness on any night. Compared to the general population, people experiencing homelessness (PEH) sleep less and experience increased daytime fatigue. A common sleep disorder and treatable cause of morbidity and low quality of life is sleep apnea. High prevalence of chronic comorbid disorders of sleep apnea in PEH suggest high prevalence of sleep apnea, but the rate of sleep apnea treatment in PEH is very low. Also, in PEH, individual and systemic barriers lead to a high rate of underdiagnosed and untreated sleep apnea. Mortality is higher in PEH than the general population, and sleep apnea remains a potential silent cause of morbidity and low quality of life in PEH. Our goal is to diagnose and treat sleep apnea in people living in shelters and to examine the effect of patient-centered treatment on their quality of life.
Eligibility
Inclusion Criteria2
- Residing in a shelter at the time of recruitment
- Age >18 years old
Exclusion Criteria2
- Allergies to medical tape \[for diagnosis study\].
- Requiring extensive dental treatment or periodontal disease with tooth mobility \[for treatment study\].
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Research assistants set up the portable polysomnography (Prodigy) for the overnight sleep study.
Based on the decision aid, patient preference, and CADTH recommendations, the sleep physicians will recommend the participant to use Auto-CPAP or MAD for six months.
Participants will complete eleven questionnaires: Stop-Bang, Insomnia severity index, Epworth sleepiness score (ESS), quality of life (FOSQ-10), Beck Depression Inventory (BDI), Chalder Fatigue Scale (CFQ), primary care post-traumatic stress disorder (PTSD) scale (PC-PTSD-5), Asthma control questionnaire (ACQ), OHIP-14, and Participant demographics. The RA will help the participants complete the questionnaires (\~one and a half hours in total).
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06620601